secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orgenesis Inc. (—)
CIK:        0001460602
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001493152-24-014329
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orgenesis subsidiary sells five OMPULs to Germfree for $8.34M, enters 10-year collaboration
--------------------------------------------------------------------------------

- Orgenesis Maryland sells five Octomera Mobile Processing Units & Labs (OMPULs) to Germfree for $8.34M.
- Germfree gets a worldwide royalty-free license to Orgenesis' Quality Management Systems Framework (OQMSF).
- Germfree will exclusively manufacture and distribute OMPULs for Orgenesis worldwide for 10 years.
- Each party pays the other a 15% commission on Net Sales of OMPULs/services when customer is introduced.
- Strategic Collaboration Committee with 3 members from each party to oversee joint marketing and sales pipeline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460602/000149315224014329/0001493152-24-014329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460602/000149315224014329/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-014329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer